Shenoy TR, et al. (2017) CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair. Ann Oncol 28(7):1495-1507
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.